For information only. Not investment advice, a recommendation, an offer or a solicitation, and without regard to any recipient’s objectives or circumstances. Figures come from third-party sources believed reliable but not guaranteed, and market data may be delayed. Past performance is not a reliable indicator of future results. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() Phillips 66PSX US · Energy · USD Current price$261.75as of Sep 22, 2026 Summary
Analyst consensusStrong Buy 3Buy 9Hold 6Sell 1Strong Sell 119 analysts 3-year price (USD)Factor profileMulti-factor score 100 / 100 Market data
Business descriptionPhillips 66 (PSX), spun off from ConocoPhillips in 2012, is a diversified energy manufacturing and logistics company. It operates as one of the largest independent petroleum refiners and marketers of petroleum products in the U.S., with operations spanning refining, midstream, chemicals (via CPChem), and marketing. Competitive moatPhillips 66 possesses a solid business profile diversified across the energy value chain. Its competitive position is supported by high-performing midstream assets and its 50% stake in Chevron Phillips Chemical Company (CPChem), which help stabilize earnings relative to pure-play refiners. In addition, the company leverages logistics flexibility (such as using Jones Act waivers) to optimize crude delivery across its refinery footprint. Recent developments
Investment risks / red flags
Financials
Classification
|
Theme Exposure
Factor Profile (Spider Chart)
TBI ModelPrice Chart (TradingView)
Symbol: PSXBusiness description
Phillips 66 (PSX), spun off from ConocoPhillips in 2012, is a diversified energy manufacturing and logistics company. It operates as one of the largest independent petroleum refiners and marketers of petroleum products in the U.S., with operations spanning refining, midstream, chemicals (via CPChem), and marketing.
Competitive moat
Phillips 66 possesses a solid business profile diversified across the energy value chain. Its competitive position is supported by high-performing midstream assets and its 50% stake in Chevron Phillips Chemical Company (CPChem), which help stabilize earnings relative to pure-play refiners. In addition, the company leverages logistics flexibility (such as using Jones Act waivers) to optimize crude delivery across its refinery footprint.
Recent developments
- Rating Downgrade: CFRA maintains a Hold rating on PSX (originally cut from Buy on 04/30/2026 due to valuation) following a 37% YTD run, noting that near-term refining tailwinds are largely priced in.
- Deleveraging Plan: After suffering $839 million in mark-to-market losses in Q1 2026 which forced short-term borrowing, management announced a clear path to reduce debt from current levels to ~$19 billion by year-end 2026 and ~$17 billion by year-end 2027, funded by operating cash flow (projected at $8 billion annually) and working capital reversals.
- Midstream Export Relief: Regulatory tailwinds have emerged as a previously feared licensing requirement for natural gas liquids (specifically propane and ethane exports to China/Asia) was removed, sustaining strong midstream export prospects.
- Chemicals Feedstock Advantage: CPChem continues to benefit from low-cost domestic ethane feedstock compared to international steam crackers, especially amid Middle East supply constraints.
Investment risks / red flags
- Leverage Volatility: High short-term debt levels following Q1 2026 mark-to-market losses necessitate disciplined capital allocation and debt-reduction execution.
- Macro & Refinery Turnarounds: Refining margin volatility, unexpected inflation, and extended turnaround periods represent notable risks.
- China Demand Exposure: A significant portion of its midstream NGL exports is sensitive to China's economic growth and chemical sector activity.
Market Data
Source: mkts.io · Sep 22, 2026, 06:00 UTC
Key Metrics
Analyst Consensus
Calendar Events
Financials
Forward Estimates
| Period | EPS Est | Rev Est |
|---|---|---|
| 0q | 10.63 | $40.68B |
| +1q | 7.57 | $39.24B |
| 0y | 28.04 | $165.43B |
| +1y | 24.90 | $148.51B |
Earnings
Rating Changes
| Date | Firm | Action | To |
|---|---|---|---|
| Sep 17, 2026 | BMO Capital | main | Outperform |
| Sep 14, 2026 | Raymond James | main | Outperform |
| Sep 14, 2026 | Morgan Stanley | main | Overweight |
| Sep 8, 2026 | UBS | main | Buy |
| Sep 3, 2026 | Piper Sandler | main | Neutral |
| Sep 1, 2026 | Wells Fargo | main | Overweight |
